Medical castration using megestrol acetate and minidose estrogen
- 31 May 1988
- Vol. 31 (5) , 371-374
- https://doi.org/10.1016/0090-4295(88)90726-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.BMJ, 1986
- Objective response and disease outcome in 59 patients with stage D2 prostatic cancer treated with either buserelin or orchiectomy Disease aggressivity and its association with response and outcomeUrology, 1986
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985
- Adrenal androgen blockade in relapsed prostate cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary studyCancer, 1982
- Cardiovascular Complications in the Treatment of Prostatic CarcinomaBritish Journal of Urology, 1981
- Bilateral orchiectomy for carcinoma of prostate Response of serum testosterone and clinical Response to subsequent estrogen therapyUrology, 1981
- Megestrol acetate for treatment of advanced carcinoma of the prostateJournal of Surgical Oncology, 1975
- Estrogen treatment for cancer of the prostate.Early results with 3 doses of diethylstilbestrol and placeboCancer, 1970
- Carcinoma of the Prostate: Treatment ComparisonsJournal of Urology, 1967